Program Start

August 2019

Dissertation Topic

Beyond the Ivory Tower: Bridging the Disconnect Between DNA Methylation Biomarker Discovery and Industry for Precision Diabetes Medicine 

Thesis Defense Date

March 11, 2022

Current Positions

Founder and CEO

Relevant Methylomics, Inc

Chief Science Officer

Behavioral Diagnostics, LLC